Avantis CIBC ETFs: factor investing arrives in Canada

Short answer: CIBC and Avantis Investors launched a lineup of eight factor-tilted ETFs in Canada between February and March 2026. They cover Canadian, U.S., international, emerging markets, and global equities with tilts toward value, smaller companies, and profitability. Management fees range from 0.19% to 0.39%. Published MERs aren’t available yet, since all eight are still within their first year of inception. They’re a different bet than cap-weighted index funds like XEQT, not a replacement for everyone.

For years, the Canadian DIY investing crowd has been listening to the Rational Reminder podcast and reading academic papers about factor investing, then realizing the cleanest ways to implement it lived in U.S.-listed funds. The standard workaround was to buy the U.S.-listed Avantis ETFs in a USD account, deal with currency conversion, and stitch your own thing together. That worked for the determined and frustrated everyone else.

Between February and March 2026, CIBC partnered with Avantis Investors to bring the strategy to Canada in eight Canadian-listed ETFs. All eight are trading as of this writing. The reason this got so much attention isn’t really about CIBC, it’s that a methodology that had a small but loyal following in Canada is now available without the workarounds.

This guide is the lineup overview. If you want a head-to-head between the all-equity option and XEQT, I covered that separately in CAGE vs XEQT. This one is about what the whole lineup is, who Avantis is, and how to think about where any of these might fit.

This is not financial advice. I’m sharing what I’ve learned from my own research, and your situation might be different from mine. Fund compositions, MERs, and launch dates change. Always check the current details before making any decisions.

The lineup

Eight ETFs total, all trading as of this writing. CIBC handles the Canadian wrapper and distribution. Avantis Investors, a unit of American Century, runs the underlying strategy.

The Avantis CIBC ETF lineup

Ticker	Name	Listed	Mgmt fee
CACE.TO	Avantis CIBC Canadian Equity ETF	Feb 20, 2026	0.19%
CAUS.TO	Avantis CIBC U.S. All-Cap Equity ETF	Feb 20, 2026	0.19%
CALV.TO	Avantis CIBC U.S. Large Cap Value ETF	Feb 20, 2026	0.25%
CAUV.TO	Avantis CIBC U.S. Small Cap Value ETF	Feb 20, 2026	0.35%
CADE.TO	Avantis CIBC International Equity ETF	Mar 13, 2026	0.29%
CASV.TO	Avantis CIBC Global Small Cap Value ETF	Mar 13, 2026	0.39%
CAGE.TO	Avantis CIBC All-Equity Asset Allocation ETF	Mar 18, 2026	0.28%
CAEM.TO	Avantis CIBC Emerging Markets Equity ETF	Mar 31, 2026	0.39%

One note on the table. These are management fees, not MERs. CIBC isn’t publishing an MER for any of the eight yet because regulators don’t allow it in the first year after a fund’s inception. Once each fund crosses its one-year mark, the published MER will reflect operating costs on top of the management fee, and will run a few basis points higher.

The cheapest funds in the lineup (CACE and CAUS at 0.19%) are competitive on cost with the broad cap-weighted ETFs most Canadians already know. The deeper-tilt funds (CASV and CAEM at 0.39%) charge more because the screening and trading is more involved. None of these are expensive in the absolute sense, but the cost gap between the cheapest and the most tilted is meaningful if you’re holding for thirty years.

Who Avantis is, and why this matters

Avantis Investors launched in 2019, founded by people who had spent years at Dimensional Fund Advisors. Dimensional is the firm that, more than anyone else, turned the academic work of Eugene Fama and Kenneth French into actual investable products. For decades, getting access to Dimensional funds in Canada effectively required going through an advisor on their approved list. They were not a retail product.

Avantis took the same intellectual lineage and made it retail-accessible in the U.S. AVUV (small-cap value), AVGE (all-equity), and the rest of the Avantis lineup became staples of the Bogleheads-adjacent corner of the internet. The Rational Reminder community in Canada followed closely, and the hosts have interviewed Eduardo Repetto, the Avantis chief investment officer, more than once.

How this approach stacks up against the alternatives is its own question: Avantis vs Vanguard covers factor tilting versus plain cap-weighted indexing, and Avantis vs Dimensional covers the shared lineage and why access, not philosophy, is the real difference for a Canadian.

The thing that’s new in Canada isn’t the strategy. The strategy has been around for forty years in academic form and almost a decade in retail form. What’s new is that you can buy it in Canadian dollars, in a Canadian-listed ETF, in a TFSA or RRSP, without thinking about FX or paperwork. That removes most of the practical reasons people didn’t bother before.

What “factor tilt” means, briefly

If you’ve already read the CAGE vs XEQT guide, skip ahead. If not, here’s the version that fits in this article.

A standard index fund like XEQT is cap-weighted. It owns the global stock market in proportion to company size, so the biggest companies get the biggest weights. That’s the default approach and it works well.

A factor-tilted fund deliberately weights things differently, based on academic research that suggests certain characteristics have produced higher returns over very long horizons. Avantis tilts toward three:

• Value. Cheaper stocks (low price relative to book value, earnings, or cash flow) get more weight than they would in a cap-weighted index.
• Size. Smaller companies get more weight than their market cap alone would give them.
• Profitability. Companies that are reliably profitable get included or overweighted; chronically unprofitable ones get filtered out or down-weighted.

The honest caveat is the same one that applies to all factor investing. These tilts can underperform broad cap-weighted indices for ten years or more at a stretch. That’s not the strategy being broken. It’s how factor returns work. Holding any of these funds is a multi-decade commitment that requires sitting through long stretches of trailing the index without flinching.

If you’re new to the idea that not every ETF tracks a passive index, the not-all-ETFs-are-passive guide is a useful detour.

Three ways the lineup gets used

The eight tickers cover a wide range of needs, and people will use them in very different ways depending on how much they want to manage. Three patterns are likely to emerge.

Pattern 1: One ticker, done. Buy CAGE, set up an automatic contribution, ignore. Same shape as the just-buy-XEQT approach, just with a factor tilt baked in. CAGE handles the global equity allocation internally as a fund-of-funds across the underlying Avantis funds. This is the option for people who want the methodology without doing any work.

Pattern 2: Tilt one piece of an existing portfolio. Hold XEQT or VEQT as the core and add a slice of CAUV (U.S. small-cap value) or CASV (global small-cap value) for a targeted small-value tilt. This is what people who like the academic case for small-value but don’t want a full factor portfolio tend to do. The risk here is the slice ends up too small to matter, or you panic-sell the tilt during a bad stretch and crystallize the loss. The CAGE vs CASV comparison walks through how the two funds fit different jobs in a portfolio.

Pattern 3: Build the whole thing from individual pieces. CACE for Canada, CAUS for U.S. broad, CALV for U.S. large value, CAUV for U.S. small value, CADE for international developed, and CAEM for emerging markets. Set your own country weights, control your own rebalancing, accept the rebalancing work. This is the route for people who want the granular control and have a clear view on country allocation. It’s also more work than most people will actually do consistently.

Pattern 1 is going to be the most common. Pattern 3 sounds appealing to a lot of people right up until the second year of doing it manually.

Cost and structure things to flag

A few practical points that aren’t obvious from the marketing pages.

The cost spread inside the lineup is real. CAGE at 0.28% sits a bit above XEQT after BlackRock’s December 2025 fee cut. CASV at 0.39% is meaningfully more. Neither is unreasonable for what they do, but if you’re building a portfolio out of multiple funds, your blended fee can easily land above 0.30%. That’s still cheap by any historical standard, just not the floor that the headline CACE and CAUS numbers suggest.

Most of these are fund-of-funds. CAGE in particular is a wrapper around the underlying Avantis ETFs. That’s the same structure XEQT and VEQT use. It works fine, but it adds a small layer to how distributions and foreign withholding tax flow through, especially in non-registered accounts. The full picture only becomes clear after a year or two of distribution cycles.

These funds are new in Canada. Avantis has a U.S. track record going back to 2019, but the Canadian-listed wrappers have weeks or months of history. Things like tracking of the underlying U.S.-listed funds, distribution patterns, and how the fund-of-funds layer behaves in practice are still being established. Not necessarily a problem, just unproven in the Canadian listing.

Quarterly distributions. All of the new Avantis CIBC ETFs are set up to distribute quarterly. Worth knowing for anyone who’s used to monthly distributions from products like VFV.

If you’re working through the broader checklist for evaluating a new ETF, the how to pick ETFs in Canada guide covers the standard criteria.

What’s not in the lineup

A couple of gaps worth naming, because they shape who this lineup is and isn’t for.

There are no fixed income funds. The whole lineup is equity. If you want an Avantis-style portfolio that includes bonds, you’re either pairing one of these funds with a separate bond ETF or waiting to see whether Avantis brings their U.S.-listed bond strategies to Canada later.

There’s no global ex-North America small-cap value fund yet. CASV covers global small-cap value, which includes the U.S. and Canada. CAUV is U.S. small-cap value specifically. People who want a clean international-only small-value tilt have to wait or work around it. The CASV ETF guide breaks down the global small-cap value fund in full, and CASV vs AVUV covers the Canadian-listed-versus-U.S.-listed decision.

CAEM (emerging markets) only launched on March 31, 2026, so it has the shortest track record of the eight. Until it listed, anyone using the lineup as a complete portfolio had to either hold CAGE (which includes EM internally) or add a separate EM fund. That gap is now closed in principle, but in practice the Canadian-listed history is still very short.

Who this lineup is, and isn’t, for

Worth saying plainly.

If you already hold XEQT or VEQT and you don’t have a clear view on factor investing, you almost certainly don’t need to do anything. The launch of a new lineup is not a signal that your current setup is broken. The most common mistake when a new product gets coverage is assuming you should already be in it. That’s almost never true. The XEQT/VEQT/XGRO comparison is still the right starting point for most one-ticker investors.

If you’ve been building an Avantis portfolio in a USD account using the U.S.-listed funds, the Canadian lineup probably simplifies your life considerably. One currency, one tax slip per fund, no Norbert’s Gambit. The math on whether to switch existing U.S.-listed positions is a different question (taxable account implications, FX timing, embedded gains), but for new contributions, the Canadian-listed version is the cleaner path.

If you have a real conviction about factor investing, meaning you can articulate why you believe in the value, size, and profitability tilts and are prepared to hold through ten-plus years of underperformance, then this lineup makes the strategy more practical to express in Canada than it has ever been. “Real conviction” is the load-bearing phrase. Conviction held lightly tends to evaporate the first time the strategy lags the index.

If factor investing is new to you and the appeal is mainly that it sounds clever, this is the wrong reason to switch from a boring portfolio that doesn’t need babysitting. The strategy is real, but the discipline it requires is harder than the strategy itself.

Bottom line

The Avantis CIBC lineup is a credible group of factor-tilted ETFs from a manager with a real intellectual lineage, available in Canadian dollars in wrappers that didn’t exist here before. For people who already wanted to invest this way, it removes most of the practical friction that kept the strategy U.S.-only. For people who didn’t want to invest this way, nothing has changed.

The interesting thing isn’t any single ticker in isolation. It’s that the option exists at all. What you do with that depends on whether the factor case is something you’ve thought about for years or something you heard about last week.